CLINICAL TRIALS PROFILE FOR PENNSAID
✉ Email this page to a colleague
All Clinical Trials for PENNSAID
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01119898 ↗ | Exploratory Study of PENNSAID Gel to Treat Symptoms of Knee Osteoarthritis | Completed | Mallinckrodt | Phase 2 | 2010-08-02 | Osteoarthritis (OA) is the most common form of arthritis. It can cause pain, swelling, and reduced motion in the joints. That can reduce quality of life. OA can occur in any joint, but usually affects the hands, knees, hips or spine. The purpose of this study is to find out if doctors might be able to use 2% PENNSAID gel to treat OA in the knee. |
| NCT01202799 ↗ | Pharmacokinetics, Bioavailability and Safety of PENNSAID® Gel | Completed | Mallinckrodt | Phase 1 | 2010-09-01 | It is anticipated that PENNSAID Gel will minimize systemic exposure versus oral diclofenac administered twice a day (BID). In addition, PENNSAID Gel should result in greater subject convenience and compliance with a comparable bioavailability, safety and tolerability profile to that of the approved PENNSAID solution administered four times a day (QID). |
| NCT01350622 ↗ | Efficacy of PENNSAID® for Pain Management in the Emergency Department | Withdrawn | Medtronic - MITG | N/A | 2011-12-01 | The primary objective of this study is to compare the pain relieving effect and speed of onset of PENNSAID to that of standard oral diclofenac under double blind conditions using a growth curve approach to pain measurement. The investigators will test the hypothesis that PENNSAID will provide more rapid pain relief than oral diclofenac during the ED visit. The secondary goal of the proposed work is to discover and model the onset and course of pain relief during the emergency department (ED) visit. |
| NCT01350622 ↗ | Efficacy of PENNSAID® for Pain Management in the Emergency Department | Withdrawn | University of Utah | N/A | 2011-12-01 | The primary objective of this study is to compare the pain relieving effect and speed of onset of PENNSAID to that of standard oral diclofenac under double blind conditions using a growth curve approach to pain measurement. The investigators will test the hypothesis that PENNSAID will provide more rapid pain relief than oral diclofenac during the ED visit. The secondary goal of the proposed work is to discover and model the onset and course of pain relief during the emergency department (ED) visit. |
| NCT01350622 ↗ | Efficacy of PENNSAID® for Pain Management in the Emergency Department | Withdrawn | Virgil Davis | N/A | 2011-12-01 | The primary objective of this study is to compare the pain relieving effect and speed of onset of PENNSAID to that of standard oral diclofenac under double blind conditions using a growth curve approach to pain measurement. The investigators will test the hypothesis that PENNSAID will provide more rapid pain relief than oral diclofenac during the ED visit. The secondary goal of the proposed work is to discover and model the onset and course of pain relief during the emergency department (ED) visit. |
| NCT01508676 ↗ | Effects of Pennsaid on Clinical Neuropathic Pain | Completed | Massachusetts General Hospital | N/A | 2011-11-01 | The purpose of this study is to see if the drug Pennsaid (Diclofenac) can help reduce pain felt by people with chronic nerve pain. The drug will be used 2-4 times each day for 2 weeks. The U.S. Food and Drug Administration (FDA) has approved Pennsaid to treat osteoarthritis (bone pain), but the FDA has not approved Pennsaid to treat neuropathic (nerve) pain. The research study will compare Pennsaid to placebo. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PENNSAID
Condition Name
Clinical Trial Locations for PENNSAID
Trials by Country
Clinical Trial Progress for PENNSAID
Clinical Trial Phase
Clinical Trial Sponsors for PENNSAID
Sponsor Name
